Literature DB >> 11430592

Effect of progesterone on the contractile response of isolated pulmonary artery in rabbits.

H F Li1, T Z Zheng, W Li, S Y Qu, C L Zhang.   

Abstract

The purpose of this study was to assess the direct effect of progesterone on rabbit pulmonary arteries and to examine the mechanism of its action. Rings of pulmonary artery from male rabbits were suspended in organ baths containing Krebs solution, and isometric tension was measured. The response to progesterone was investigated in arterial rings contracted with noradrenaline (NA), KCl, and CaCl2. The effects of endothelium, nitric oxide (NO), prostaglandins, cyclic GMP (cGMP), and the adrenergic beta-receptor on progesterone-induced relaxation were also assessed. Progesterone inhibited the vasocontractivity to NA, KCl, and CaCl2, and relaxed rabbit pulmonary artery. The relaxing response of progesterone in pulmonary artery was significantly reduced by removal of endothelium, inhibitors of nitric oxide synthase and guanylate cyclase, but not by prostaglandin synthase inhibitor and blockage of the adrenergic beta-receptor. In Ca2+-free (0.1 mM EGTA) Krebs solution, progesterone inhibited NA-induced contraction that was intracellular Ca2+-dependent, but didn't affect the contraction of extracellular Ca2+-dependent component. Our results suggest that progesterone induces relaxation of isolated rabbit pulmonary arteries partially via NO and cGMP. Progesterone may also inhibit Ca2+ influx through potential-dependent calcium channels (PDCs) and Ca2+ release from intracellular stores.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430592

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  9 in total

Review 1.  Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.

Authors:  James Hester; Corey Ventetuolo; Tim Lahm
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 2.  Sex differences in the pulmonary circulation: implications for pulmonary hypertension.

Authors:  Yvette N Martin; Christina M Pabelick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-07       Impact factor: 4.733

Review 3.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

4.  Non-genomic vasorelaxant effects of 17β-estradiol and progesterone in rat aorta are mediated by L-type Ca2+ current inhibition.

Authors:  Elisa Cairrão; Ezequiel Alvarez; João Miguel Carvas; Antonio Jose Santos-Silva; Ignacio Verde
Journal:  Acta Pharmacol Sin       Date:  2012-04-02       Impact factor: 6.150

Review 5.  Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease.

Authors:  Stevan P Tofovic
Journal:  J Cardiovasc Pharmacol       Date:  2010-12       Impact factor: 3.105

6.  Effect of progesterone on nitric oxide/cyclic guanosine monophosphate signaling and contraction in gastric smooth muscle cells.

Authors:  Othman A Al-Shboul; Ayman G Mustafa; Amal Abu Omar; Ahmed N Al-Dwairi; Mohammad A Alqudah; Mona S Nazzal; Mahmoud A Alfaqih; Rami A Al-Hader
Journal:  Biomed Rep       Date:  2018-10-18

7.  Maternal progesterone level in fetal growth restriction and its relationship with Doppler velocimetry indices.

Authors:  S Borna; M Bandarian; A Abdollahi; F Bandarian; M Malek
Journal:  Iran J Radiol       Date:  2011-03-30       Impact factor: 0.212

8.  Characterization of the vasodilatory action of testosterone in the human pulmonary circulation.

Authors:  Alyson M Smith; Robert T Bennett; T Hugh Jones; Mike E Cowen; Kevin S Channer; Richard D Jones
Journal:  Vasc Health Risk Manag       Date:  2008

9.  Effect of Dydrogesterone on the Outcome of Idiopathic Intrauterine Growth Restriction: A Double-blind Clinical Trial Study.

Authors:  Elaheh Zarean; Fatemeh Mostajeran; Zahra Dayani
Journal:  Adv Biomed Res       Date:  2018-06-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.